Authors:
Gonzalez, I
Ohsawa, N
Singer, RH
Devillers, M
Ashizawa, T
Balasubramanyam, A
Cooper, TA
Khajavi, M
Lia-Baldini, AS
Miller, G
Philips, AV
Timchenko, LT
Waring, J
Yamagata, H
Barbet, JP
Klesert, TR
Tapscott, SJ
Roses, AD
Wagner, M
Baiget, M
Martorell, L
Browne, GB
Eymard, B
Gourdon, G
Junien, C
Seznec, H
Carey, N
Gosling, M
Maire, P
Gennarelli, M
Sato, S
Ansved, T
Kvist, U
Eriksson, M
Furling, D
Chen, EJ
Housman, DE
Luciano, B
Siciliano, M
Spring, N
Shimizu, M
Eddy, E
Morris, GE
Krahe, R
Furuya, H
Adelman, J
Pribnow, D
Furutama, D
Mathieu, J
Hilton-Jones, D
Kinoshita, M
Abbruzzese, C
Sinden, RR
Wells, RD
Pearson, CE
Kobayashi, T
Johansson, A
Salvatori, S
Perryman, B
Swanson, MS
Gould, FK
Harris, SE
Johnson, K
Mitchell, AM
Monckton, DG
Winchester, CL
Antonini, G
Day, JW
Liquori, C
Ranum, LPW
Westerlaken, J
Wieringa, B
Griffith, JD
Michalowski, S
Moore, H
Hamshere, M
Korade, Z
Thornton, CA
Jaeger, H
Lehmann, F
Moorman, JR
Mounsey, JP
Mahadevan, MS
Citation: I. Gonzalez et al., New nomenclature and DNA testing guidelines for myotonic dystrophy type 1(DM1), NEUROLOGY, 54(6), 2000, pp. 1218-1221